Lamotrigine Farmax

Lamotrigine, the active ingredient in Lamotrigine Farmax, is an anticonvulsant presented as an oral tablet for oral use. It is used to control seizures in epilepsy and to stabilize mood in adults with bipolar disorder. It belongs to the class of sodium channel blockers and is indicated for partial seizures, generalized tonic‑clonic seizures, and as maintenance therapy in bipolar I disorder.

GNH USA supplies Lamotrigine Farmax as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution.

Lamotrigine is an anticonvulsant that modulates neuronal excitability in seizure disorders and mood stabilization.

- Epilepsy: reduces the frequency of partial and generalized seizures in patients of various ages. - Bipolar disorder: provides maintenance therapy to prevent mood episodes in adults with bipolar I disorder. - Partial seizures: decreases occurrence of focal onset seizures with or without secondary generalization. - Generalized tonic‑clonic seizures: helps control convulsive episodes in patients with epilepsy.

Lamotrigine may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Dizziness: transient sensation of light‑headedness. - Headache: mild to moderate pain often resolving with continued therapy. - Nausea: gastrointestinal upset that may lessen over time. - Rash: mild skin irritation that requires monitoring. - Blurred vision: temporary visual disturbances. - Insomnia: difficulty falling or staying asleep.

Serious or Rare Side Effects: - Stevens‑Johnson syndrome: severe skin reaction requiring immediate discontinuation. - Toxic epidermal necrolysis: life‑threatening skin detachment. - Aseptic meningitis: inflammation of the meninges without infection. - Blood dyscrasias: rare cases of agranulocytosis or aplastic anemia. - Hepatic failure: severe liver injury in susceptible individuals.

When prescribing Lamotrigine Farmax, clinicians should observe several safety measures.

- Titration: follow a gradual dose‑increase schedule to reduce rash risk. - Skin reactions: discontinue immediately if a rash or hypersensitivity develops. - Concomitant valproate: may require dose adjustment due to increased plasma levels. - Pregnancy: use only if benefit outweighs potential risk; discuss with physician. - Renal/hepatic impairment: monitor and adjust dose as needed. - Store below 25°C: keep in the original pack, protect from moisture.

Lamotrigine Farmax interacts with several medicines; awareness of the interaction level guides clinical decisions.

Major Interactions (Avoid): - Valproic acid: markedly increases lamotrigine concentrations, raising toxicity risk. - Carbamazepine: reduces lamotrigine levels, potentially compromising efficacy. - Oral contraceptives: lower lamotrigine exposure, may require dose increase.

Moderate Interactions (Monitor Closely): - Other enzyme inducers (e.g., phenytoin, phenobarbital): may decrease lamotrigine levels. - Serotonergic agents: monitor for signs of serotonin syndrome when combined with certain antidepressants.